Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian J Mair

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccineDominic Fong, Maximilian J Mair, Manfred Mitterer
International Journal of Cancer|October 5, 2021
Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic waveDominic Fong, Maximilian J Mair, Florian Lanthaler, et al.
Journal of Neuro-Oncology|October 1, 2022
Emerging systemic treatment options in meningiomaMaximilian J Mair, Anna S Berghoff, Priscilla K Brastianos, et al.
Cancer Treatment Reviews|November 23, 2020
A basic review on systemic treatment options in WHO grade II-III gliomasMaximilian J Mair, Marjolein Geurts, Martin J van den Bent, et al.
JAMA Oncology|September 22, 2022
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With CancerMaximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
Neuro-Oncology|May 4, 2024
Radioligand therapies in meningioma: Evidence and future directionsMaximilian J Mair, Emeline Tabouret, Derek R Johnson, et al.
Journal of Neuro-Oncology|March 2, 2021
LAG-3 expression in the inflammatory microenvironment of gliomaMaximilian J Mair, Barbara Kiesel, Katharina Feldmann, et al.
British Journal of Cancer|February 11, 2022
Correction: Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastasesAngelika M Starzer, Ariane Steindl, Maximilian J Mair, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and TheranosticsJan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Immunotherapy for brain metastases and primary brain tumorsAnna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccineDominic Fong, Maximilian J Mair, Manfred Mitterer
International Journal of Cancer|October 5, 2021
Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic waveDominic Fong, Maximilian J Mair, Florian Lanthaler, et al.
Journal of Neuro-Oncology|October 1, 2022
Emerging systemic treatment options in meningiomaMaximilian J Mair, Anna S Berghoff, Priscilla K Brastianos, et al.
Cancer Treatment Reviews|November 23, 2020
A basic review on systemic treatment options in WHO grade II-III gliomasMaximilian J Mair, Marjolein Geurts, Martin J van den Bent, et al.
JAMA Oncology|September 22, 2022
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With CancerMaximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
Neuro-Oncology|May 4, 2024
Radioligand therapies in meningioma: Evidence and future directionsMaximilian J Mair, Emeline Tabouret, Derek R Johnson, et al.
Journal of Neuro-Oncology|March 2, 2021
LAG-3 expression in the inflammatory microenvironment of gliomaMaximilian J Mair, Barbara Kiesel, Katharina Feldmann, et al.
British Journal of Cancer|February 11, 2022
Correction: Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastasesAngelika M Starzer, Ariane Steindl, Maximilian J Mair, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and TheranosticsJan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Immunotherapy for brain metastases and primary brain tumorsAnna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, et al.
Pageof 5